These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Detection of cytoplasmic and surface membrane markers in cells of some human hematopoietic cell lines. Koníková E, Babusíková O, Kusenda J, Glasová M. Neoplasma; 1992; 39(6):337-42. PubMed ID: 1491722 [Abstract] [Full Text] [Related]
4. Leukemia-associated marker combinations in acute leukemia suitable for detection of minimal residual disease. Babusíková O, Mesárosová A, Koníková M, Kusenda J, Glasová M, Klobusická M. Neoplasma; 1993; 40(5):275-81. PubMed ID: 8272155 [Abstract] [Full Text] [Related]
5. The reliability of cytoplasmic CD3 and CD22 antigen expression in the immunodiagnosis of acute leukemia: a study of 500 cases. Janossy G, Coustan-Smith E, Campana D. Leukemia; 1989 Mar; 3(3):170-81. PubMed ID: 2465463 [Abstract] [Full Text] [Related]
10. Evaluation of ricin A chain-containing immunotoxins directed against CD19 and CD22 antigens on normal and malignant human B-cells as potential reagents for in vivo therapy. Ghetie MA, May RD, Till M, Uhr JW, Ghetie V, Knowles PP, Relf M, Brown A, Wallace PM, Janossy G. Cancer Res; 1988 May 01; 48(9):2610-7. PubMed ID: 2451562 [Abstract] [Full Text] [Related]
11. B cell antigen receptor-mediated apoptosis. Importance of accessory molecules CD19 and CD22, and of surface IgM cross-linking. Chaouchi N, Vazquez A, Galanaud P, Leprince C. J Immunol; 1995 Apr 01; 154(7):3096-104. PubMed ID: 7534787 [Abstract] [Full Text] [Related]
12. Flow cytometric detection of some activation and proliferation markers in human hematopoietic cell lines. Glasová M, Koníková E, Kusenda J, Babusíková O. Neoplasma; 1996 Apr 01; 43(6):381-8. PubMed ID: 8996562 [Abstract] [Full Text] [Related]